Propanc Biopharma, Inc.
About
1.82USD+0.12 +7.06%
Closed • Updated at 06:58 GMT+00:00Market Cap$4.15M
Volume68.4K
Beta1.02
RSI39.29
Propanc Biopharma, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 20 2026
Propanc Biopharma’s CEO Forecasts New Medical Breakthroughs in the Fight Against Pancreatic Cancer Over the Next Decade
May 19 2026
Propanc Biopharma Engages European CDMO for GMP Production of PRP for Phase 1b, FIH Study in 30 – 40 Advanced Cancer Patients
May 15 2026
Propanc Biopharma Provides Corporate Update and Reports Third Quarter 2025/26 Results
May 14 2026
Propanc Biopharma Implements Reverse Stock Split to Support Continued Nasdaq Listing and Growth Plans
Mar 24 2026
Propanc Biopharma Executes Multi-Yr, Anti-Aging & Cancer Research Collaboration with the Universities of Jaén and Granada, Spain
Community Chat
Ask AI
Try asking